How does Baclofen primarily act on motor neurons to reduce spasticity at its main site of action?
By inhibiting the release of excitatory neurotransmitters from presynaptic terminals.
Baclofen exerts its therapeutic effect against spasticity by targeting GABA-B receptors, which are predominantly located on the presynaptic terminals within the spinal cord. When Baclofen activates these receptors, the resulting signaling cascade acts to inhibit the further release of excitatory neurotransmitters. By reducing the signaling input from the presynaptic side, Baclofen effectively dampens the excitability of the motor neurons responsible for causing the pathological muscle stiffness (spasticity). This targeted presynaptic inhibition is what differentiates its mechanism from the generalized CNS depression caused by GABA-A modulators like diazepam.
